Monthly rifampicin, ofloxacin, and minocycline therapy for generalized and localized granuloma annulare | Zendy

Shilpa Garg | Zendy; Sukriti Baveja | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Monthly rifampicin, ofloxacin, and minocycline therapy for generalized and localized granuloma annulare

Author(s) -

Shilpa Garg,

Sukriti Baveja

Publication year - 2015

Publication title -

indian journal of dermatology venereology and leprology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.514

H-Index - 45

eISSN - 0973-3922

pISSN - 0378-6323

DOI - 10.4103/0378-6323.148564

Subject(s) - granuloma annulare , medicine , minocycline , rifampicin , dermatology , surgery , incidence (geometry) , ofloxacin , antibiotics , pathology , tuberculosis , ciprofloxacin , physics , optics , microbiology and biotechnology , biology

The localized form of granuloma annulare is usually self-limiting, resolving within 2 years. Generalized granuloma annulare, on the other hand, runs a protracted course, with spontaneous resolution being rare. It is also characterized by a later age of onset, an increased incidence of diabetes mellitus, poor response to therapy, and an increased prevalence of HLA Bw35.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research